Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Pentoxifylline and Metformin in Alopecia Areata
NCT06087796Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of pentoxifylline PKB171 gel and metformin 1% gel in alopecia areata (3 arms), sponsored by Assiut University. Primary endpoint: Severity of Alopecia Tool Score at 8 months. Status: unknown.
02
Drugs
pentoxifylline PKB171 gelmetformin 1% gel
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06087796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087796.